Innovative healthcare service ensures patients around the world get the support they need, even in a pandemic
OTTAWA, August 18, 2021 – Calian® Group Ltd. (TSX: CGY), deliverer of trusted solutions across Advanced Technologies, Health, Learning and IT & Cyber Solutions segments, announced an expansion of clinical trial and patient support programs (PSPs) to pharmaceutical customers in eight new markets.
Calian Health delivers on-demand nursing support at the most convenient location for the patient – whether at home, work, pharmacy or clinic. This expansion brings timely, high-quality care to patients in European countries and the US. While this announcement is not material, it represents a significant milestone in Calian service line evolution and customer diversification growth pillars.
The expansion is the direct result of overachieving industry target metrics during a 2020 pharmaceutical clinical trial pilot program. The pilots were implemented to re-start previous, non-Calian programs that had experienced service interruptions during the pandemic. The pilot program quickly surpassed key performance indicators for the industry. Calls to international call centers were answered within two minutes and patients requiring in-home nursing services were assigned to a nurse within 45 minutes – far surpassing the industry standard of 48 hours – and first patient visits were completed in four days, reducing the time to care by +70%, based on the industry average of 14 days.
“When we were approached by our client to help resolve a pandemic-related service interruption, we were able to respond quickly because of our patient support expertise and existing infrastructure, at the heart of which is our proprietary resource management software platform,” said Jeff Smith, President, Alio Health, a Calian company. “Expanding on this proven approach to customers in new markets is a natural evolution of our service platform.”
Within weeks of the successful clinical trial pilot, Calian Health expanded its home healthcare services to customers across eight new markets. By January 2021, the company had onboarded personnel internationally and welcomed its first patient enrollment in the Netherlands.
“We are excited to work with our global partners, to deliver clinical services that go beyond industry expectations by leveraging a new model for high-quality, cost-effective healthcare,” said Gordon McDonald, President, Calian Health.
Calian Health continues to expand its international infrastructure to offer a suite of healthcare services globally. These include nursing support for medication administration, specimen collection, ECG monitoring, clinical trials, reimbursement assistance and more. The company has located offices in each region to ensure local support and to secure patient data in compliance with regional and international privacy regulations. Today, Calian Health operates across Canada, US, Belgium, France, Germany, Hungary, Netherlands, Poland and Spain, with plans to expand further in Europe, and North and South America in 2022.
Read the Case Study in its entirety to learn how Alio Health Solves Pandemic Service Interruptions to Ensure Success of Clinical Trial.
About Alio Health, a Calian company
Since its launch in 2012, Alio Health Services has grown rapidly in the areas of patient support program (PSP) management and health resource optimization. Alio Health specializes in the design and implementation of comprehensive patient support programs that enhance the patient’s experience throughout their treatment journey. Its services are enabled by an innovative software application which streamlines the scheduling and delivery of health services for hospitals, health care institutions and home care locations. Driven by proprietary systems and system automation, Alio patient support programs ensure superior quality control and the provision of more cost-effective in-home services.
About Calian Health
Calian is one of Canada’s largest national health and psychological services organizations with decades of experience in the management of healthcare professionals and health psychological service delivery, as well as the operation and management of primary care and occupational health clinics, pharmaceutical research and patient support programs (PSPs). With a network of more than 2,400 healthcare professionals, Calian supports more than six million patient visits per year at more than 180 clinic locations across Canada. Calian Primacy clinics are located in Loblaw grocery store locations across Canada (including Real Canadian Superstore®, Zehrs®, Loblaws® and No Frills®).
À propos de Calian
Nous faisons avancer le monde. Calian® aide les gens à communiquer, à innover, à apprendre et à mener une vie saine et sûre. Chaque jour, nos employés vivent nos valeurs d’engagement envers le client, d’intégrité, d’innovation, de respect et de travail d’équipe pour concevoir des solutions fiables qui résolvent des problèmes complexes. C’est la confiance. Ingénierie. Entreprise stable et en pleine croissance depuis 40 ans, notre siège social se trouve à Ottawa et nos bureaux et projets couvrent les marchés nord-américains, européens et internationaux. Visitez calian.com pour découvrir des solutions innovantes en matière de soins de santé, de communications, d’apprentissage et de cybersécurité.
Les noms de produits ou de services mentionnés dans le présent document peuvent être des marques déposées de leurs propriétaires respectifs.
Demandes de renseignements des médias :[email protected] 613-599-8600 x 2298 Relations avec les investisseursinquiries:[email protected]
CLAUSE DE NON-RESPONSABILITÉ
Certaines informations contenues dans le présent communiqué de presse sont de nature prospective et sont soumises à des risques et incertitudes importants. Les résultats ou événements prévus dans ces déclarations peuvent différer matériellement des résultats ou événements réels. Ces déclarations sont généralement accompagnées de termes tels que “avoir l’intention”, “anticiper”, “croire”, “estimer”, “s’attendre à” ou d’autres termes similaires. Les facteurs susceptibles d’entraîner des résultats ou des événements différents des attentes actuelles comprennent, entre autres : l’impact de la concurrence sur les prix ; la rareté des professionnels qualifiés ; l’impact de l’évolution rapide des technologies et des marchés ; la perte d’activité ou le risque de crédit avec les principaux clients ; les risques techniques sur les projets à prix fixe ; les conditions générales du secteur et du marché et les taux de croissance ; la croissance internationale et les conditions économiques mondiales, y compris les fluctuations des taux de change ; et l’impact des consolidations dans l’industrie des services aux entreprises. Pour de plus amples informations concernant certains de ces facteurs et d’autres, veuillez consulter le dernier rapport annuel de la société et les autres rapports déposés par Calian auprès de la Commission des valeurs mobilières de l’Ontario. Calian décline toute intention ou obligation de mettre à jour ou de réviser les déclarations prévisionnelles, que ce soit en raison de nouvelles informations, d’événements futurs ou autres. Rien ne garantit que les résultats, performances ou réalisations réels exprimés ou sous-entendus dans les déclarations prospectives contenues dans la présente communication se produiront ou, s’ils se produisent, que des avantages pourront en être tirés.
Calian – Siège social – 770 Palladium Drive – Ottawa – Ontario – Canada – K2V 1C8
Tel : 613.599.8600 – Fax : 613-592-3664 – General info email : [email protected]
